These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain. Niu J, Scheschonka A, Druey KM, Davis A, Reed E, Kolenko V, Bodnar R, Voyno-Yasenetskaya T, Du X, Kehrl J, Dulin NO. Biochem J; 2002 Aug 01; 365(Pt 3):677-84. PubMed ID: 11985497 [Abstract] [Full Text] [Related]
6. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor. Tovey SC, Willars GB. Mol Pharmacol; 2004 Dec 01; 66(6):1453-64. PubMed ID: 15383626 [Abstract] [Full Text] [Related]
7. Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system. Wieland T, Lutz S, Chidiac P. Curr Opin Pharmacol; 2007 Apr 01; 7(2):201-7. PubMed ID: 17276730 [Abstract] [Full Text] [Related]
8. Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors. Wang X, Zeng W, Soyombo AA, Tang W, Ross EM, Barnes AP, Milgram SL, Penninger JM, Allen PB, Greengard P, Muallem S. Nat Cell Biol; 2005 Apr 01; 7(4):405-11. PubMed ID: 15793568 [Abstract] [Full Text] [Related]
9. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. Kohno T, Igarashi Y. Genes Cells; 2008 Jul 01; 13(7):747-57. PubMed ID: 18513330 [Abstract] [Full Text] [Related]
10. The RGS (regulator of G-protein signalling) and GoLoco domains of RGS14 co-operate to regulate Gi-mediated signalling. Traver S, Splingard A, Gaudriault G, De Gunzburg J. Biochem J; 2004 May 01; 379(Pt 3):627-32. PubMed ID: 15112653 [Abstract] [Full Text] [Related]
11. RGS3 and RGS4 are GTPase activating proteins in the heart. Zhang S, Watson N, Zahner J, Rottman JN, Blumer KJ, Muslin AJ. J Mol Cell Cardiol; 1998 Feb 01; 30(2):269-76. PubMed ID: 9515003 [Abstract] [Full Text] [Related]
13. Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2: roles of its N-terminal domain. Matsuzaki N, Nishiyama M, Song D, Moroi K, Kimura S. Cell Signal; 2011 Jun 01; 23(6):1041-9. PubMed ID: 21291998 [Abstract] [Full Text] [Related]
14. Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH. FASEB J; 2003 Mar 01; 17(3):440-2. PubMed ID: 12514120 [Abstract] [Full Text] [Related]
15. Multi-tasking RGS proteins in the heart: the next therapeutic target? Riddle EL, Schwartzman RA, Bond M, Insel PA. Circ Res; 2005 Mar 04; 96(4):401-11. PubMed ID: 15746448 [Abstract] [Full Text] [Related]
16. The expression patterns of RGS transcripts in platelets. Kim SD, Sung HJ, Park SK, Kim TW, Park SC, Kim SK, Cho JY, Rhee MH. Platelets; 2006 Nov 04; 17(7):493-7. PubMed ID: 17074726 [Abstract] [Full Text] [Related]
17. Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. Owen VJ, Burton PB, Mullen AJ, Birks EJ, Barton P, Yacoub MH. Eur Heart J; 2001 Jun 04; 22(12):1015-20. PubMed ID: 11428836 [Abstract] [Full Text] [Related]
18. Characterisation of a sphingosine 1-phosphate-activated Ca2+ signalling pathway in human neuroblastoma cells. Villullas IR, Smith AJ, Heavens RP, Simpson PB. J Neurosci Res; 2003 Jul 15; 73(2):215-26. PubMed ID: 12836164 [Abstract] [Full Text] [Related]